Apelin-12

Also known as: Pyr¹-Apelin-13 (short isoform); Apelin fragment 12

Overview

Apelin-12 is a short peptide fragment derived from the apelin precursor, known for its potent cardiovascular and metabolic effects. It improves blood flow, supports heart function, and enhances cellular energy metabolism. Often studied in the context of cardiovascular disease and aging, it helps protect blood vessels and may improve endurance and mitochondrial performance. Apelin-12 is one of the bioactive fragments of the apelin peptide family, acting as a high-affinity ligand for the APJ (APLNR) receptor. It is expressed in endothelial cells, cardiomyocytes, adipose tissue, and the hypothalamus. Apelin-12 modulates cardiovascular tone, glucose uptake, mitochondrial health, and angiogenesis. It also plays a regulatory role in inflammation, oxidative stress, and energy balance, making it a promising target in aging and cardiometabolic disorders.

Benefits

- Lowers blood pressure and improves vascular elasticity

- Increases cardiac output without increasing oxygen demand

- Enhances glucose uptake and metabolic flexibility

- Reduces vascular inflammation and oxidative damage

- Promotes angiogenesis and tissue perfusion in ischemic states

Consider This Peptide If You Want To

- High blood pressure, endothelial dysfunction, or heart failure

- Metabolic inflexibility or poor exercise tolerance

- Seek vascular protection, mitochondrial health, or anti-aging support

Dosage & Administration

Dosage Guidelines

Recommended Dosage

• Amount: 1 mg

• Frequency: weekly

• Duration: 1 week

• Rest Period:

• Time of Day: morning

• Ingestion: oral

Experimental dosing based on preclinical models; requires fractionation due to short half-life

Administration Routes:

- Subcutaneous

- Intravenous

Research Findings on Dosage:

Subcutaneous or Intravenous Injection (Preclinical/Experimental)

• Commonly Reported Dosage: 10–100 μg/kg in preclinical models

• Estimated Human Equivalent Dose: ~0.7–7 mg total per week (experimental)

• Duration: Acute or short-term (1–4 weeks) in animal studies

• Administration Notes: Rapid onset; dosing may require fractionation due to short half-life

Mechanism of Action

How this peptide works in the body

Activation of APJ Receptor Signaling in Cardiovascular Tissues

• Apelin-12 binds to the G protein-coupled APJ receptor on endothelial and cardiac cells, triggering Gαi and β-arrestin signaling. This activates PI3K/Akt and AMPK pathways, leading to enhanced endothelial nitric oxide synthase (eNOS) phosphorylation and nitric oxide (NO) production. The result is vasodilation, reduced vascular resistance, and improved blood perfusion.

Enhancement of Cardiac Contractility and Stroke Volume

• In cardiomyocytes, apelin-12 promotes positive inotropy by modulating calcium sensitivity via phosphorylation of myosin light chain kinase (MLCK) and increasing SERCA2a activity. This elevates cardiac output without increasing myocardial oxygen demand, a rare benefit in heart failure settings.

Improvement of Glucose Uptake and Mitochondrial Efficiency

• Apelin-12 upregulates GLUT4 translocation in skeletal muscle through activation of AMPK and increased phosphorylation of AS160. In mitochondria, it improves complex I and IV activity and reduces mitochondrial ROS via uncoupling protein 2 (UCP2) modulation. These effects enhance energy output and metabolic resilience under stress.

Regulation of Vascular Inflammation and Oxidative Stress

• Apelin-12 suppresses NF-κB translocation in vascular endothelium and inhibits NLRP3 inflammasome formation. It lowers circulating levels of pro-inflammatory cytokines (IL-1β, TNF-α) while boosting antioxidant enzyme expression (SOD, catalase). These actions help prevent endothelial dysfunction and vascular aging.

Promotion of Angiogenesis and Tissue Perfusion

• Through upregulation of VEGF-A and Angiopoietin-1, apelin-12 supports neovascularization in ischemic tissues. It also enhances EPC (endothelial progenitor cell) recruitment via SDF-1/CXCR4 signaling. These angiogenic mechanisms are important in tissue regeneration and repair following injury or ischemia.

Consider Stacking With

- BPC-157

- L-Carnitine

- Epitalon

- GDF-11

- Ventfort

Side Effects & Cautions

Common Side Effects

- Hypotension (transient) due to potent vasodilation

- Headache or flushing

Cautions

- Not yet approved for human therapeutic use

- Use caution in hypotensive patients or those with unstable cardiovascular status

Rare Side Effects

- Tachyphylaxis with repeated high dosing

- Potential off-target signaling with high APJ activation

Research & References

Research Highlights

• Sato et al., 2012: Apelin-12 enhanced cardiac contractility and reduced vascular resistance in rodent heart failure models

• Zhang et al., 2015: Demonstrated improved glucose tolerance and mitochondrial performance with apelin-12 in obese mice

• Wang et al., 2018: Showed reduced endothelial inflammation and enhanced angiogenesis after ischemia

• Gao et al., 2020: Reported protection against oxidative injury and restoration of vascular tone in aging vessels

References

• Sato T, et al. "Apelin and cardiovascular homeostasis." J Mol Cell Cardiol. 2012.

• Zhang J, et al. "Metabolic and mitochondrial effects of apelin in insulin resistance." Diabetes. 2015.

• Wang W, et al. "Apelin-12 attenuates endothelial inflammation and supports angiogenesis." Atherosclerosis. 2018.

• Gao E, et al. "Anti-aging vascular effects of apelin signaling." Circ Res. 2020.